Pancreatic Cancer Research

ResearcherMasaryk Memorial Cancer InstituteActive in the last 2 years

Petr Müller

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-8404-4494; OpenAlex author ID A5039582296. Sources: ClinicalTrials.gov.

Their work

Papers
1
Trials
1
Grants
0
Labs led
0
Collaborators
6
Papers, trials and grants by year

2022: 1 trial · 2023: none · 2024: none · 2025: 1 paper

Papers 1

  1. Targeting Hsp70 Immunosuppressive Signaling Axis with Lipid Nanovesicles: A Novel Approach to Treat Pancreatic Cancer. Co-author DOI 10.3390/cancers17071224↗

Trials 1

  1. Determining Minimal Residual Disease Using ctDNA Deep Sequencing Study director NCT07660627↗

Closest collaborators

The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Radka Lordick Obermannova · 1 shared trial, 2022 · strength 0.49
  2. Harold W. Davis · 1 shared paper, 2025 · strength 0.22
  3. Xiaoyang Qi · 1 shared paper, 2025 · strength 0.22
  4. Ahmet Kaynak · 1 shared paper, 2025 · strength 0.22
  5. Clayton S. Lewis · 1 shared paper, 2025 · strength 0.22
  6. Vladimir Y. Bogdanov · 1 shared paper, 2025 · strength 0.22

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.